Warning to the public – Market recall of Fludarabin EBEWE 50mg/2ml, batch number: EH3119, expiry date: 03/2017.

 

​Fludarabin injection serves for the treatment of cancer patients and is administered to patients by injection under the supervision of a specialist physician in the framework of oncological treatment.
 
Due to the presence of particles in this product, PharmaLogic Ltd., in coordination with the Ministry of Health, requests patients in possession of the product from this batch to return the batch to the pharmacy through which it was purchased, and to receive another unflawed batch instead.